CIHR Makes Recommendations on Canadian MS Research Priorities

Introduction

Main Digest

Today, at a press conference in Ottawa, CIHR President Dr. Alain Beaudet announced the outcomes of the discussions and shared the recommendations he has made to the Honorable Leona Aglukkaq, Minister of Health.

"There was unanimous agreement from the scientific experts that it is premature to support pan-Canadian clinical trials on the proposed "Liberation Procedure," said Dr. Beaudet. "There is an overwhelming lack of scientific evidence on the safety and efficacy of the procedure, or even that there is any link between blocked veins and MS."

"The MS Society of Canada is a leading funder of MS research, so it was important for us to attend the August 26 meeting," said Yves Savoie, CEO and President of the MS Society of Canada. "We and the US National MS Society committed $2.4 million last June to support seven research teams to focus on chronic cerebrospinal venous insufficiency (CCSVI) and its relationship to MS. We firmly believe the studies currently under way are critical to advance understanding in this area of MS research." (MS Society news release, June 11, 2010: mssociety.ca/en/releases/nr_20100611.htm)

Dr. Beaudet has made the following three recommendations to the Minister of Health:

1. To establish a scientific expert working group made up of the principal investigators for the seven MS Society-sponsored studies (four from Canada and three from the US), scientific leadership from CIHR and the MS Societies, and a representative from the provinces and territories, to monitor and analyze preliminary and final results from these studies, as well as from related studies from around the world. The first meeting of this expert working group should take place in this calendar year.

2. Based on the outcomes of these studies, the scientific expert working group should reach conclusions regarding (1) the association (or lack thereof) between impaired cerebral venous drainage and MS; and (2) a common standard for reliably diagnosing the condition using imaging or other techniques.

3. Depending on these conclusions, the scientific expert working group should make recommendations on further studies including, if appropriate, a pan-Canadian interventional clinical trial.

Thursday's meeting consisted of a review of evidence, current international efforts and knowledge gaps, with an emphasis on the potential links between CCSVI and MS; a thorough review of past, current and proposed clinical trials; and the identification of clinical research priorities for Canada. Participants represented a range of disciplines including neuro- and cardio-imaging, immunology, neurosurgery, vascular surgery, pathology, neurology and intervention radiology.

"CIHR will continue to work with the MS Society of Canada and Health Canada to advance safe, evidence-based research and innovation on this devastating disease, which affects so many Canadians," Dr. Beaudet concluded.

About the Canadian Institutes of Health Research -For the past 10 years, the Canadian Institutes of Health Research (CIHR) has supported better health and health care for Canadians. As the Government of Canada's health research investment agency, CIHR enables the creation of evidence-based knowledge and its transformation into improved treatments, prevention and diagnoses, new products and services, and a stronger, patient-oriented health-care system. Composed of 13 internationally recognized Institutes, CIHR supports more than 13,600 health researchers and trainees across Canada. www.cihr-irsc.gc.ca

Related Publications▶ Share This Page

Page Information, Citing and Disclaimer

Disabled World is a comprehensive online resource that provides information and news related to disabilities, assistive technologies, and accessibility issues. Founded in 2004 our website covers a wide range of topics, including disability rights, healthcare, education, employment, and independent living, with the goal of supporting the disability community and their families.

Cite This Page (APA): Canadian Institutes of Health Research. (2010, September 1). CIHR Makes Recommendations on Canadian MS Research Priorities. Disabled World. Retrieved September 7, 2024 from www.disabled-world.com/health/autoimmunediseases/ms/ms-research-canada.php

Permalink: <a href="https://www.disabled-world.com/health/autoimmunediseases/ms/ms-research-canada.php">CIHR Makes Recommendations on Canadian MS Research Priorities</a>: Meeting of leading North American experts in multiple sclerosis (MS) to identify research priorities for Canada.

Disabled World provides general information only. Materials presented are never meant to substitute for qualified medical care. Any 3rd party offering or advertising does not constitute an endorsement.